The search for a reliable biomarker in predicting cancer prognosis has led to numerous studies investigating plasma suPAR or uPAR in tumor tissue for improving the diagnosis of cancer, [26] measuring recurrence risk in patients receiving curative surgery, [27], [28] and predicting cancer development in high-risk individuals.[29]. The gene discussed is PLAUR; the disease is neoplasm.